381 related articles for article (PubMed ID: 27711076)
1. Cnbp ameliorates Treacher Collins Syndrome craniofacial anomalies through a pathway that involves redox-responsive genes.
de Peralta MS; Mouguelar VS; Sdrigotti MA; Ishiy FA; Fanganiello RD; Passos-Bueno MR; Coux G; Calcaterra NB
Cell Death Dis; 2016 Oct; 7(10):e2397. PubMed ID: 27711076
[TBL] [Abstract][Full Text] [Related]
2. Proteasomal inhibition attenuates craniofacial malformations in a zebrafish model of Treacher Collins Syndrome.
Rosas MG; Lorenzatti A; Porcel de Peralta MS; Calcaterra NB; Coux G
Biochem Pharmacol; 2019 May; 163():362-370. PubMed ID: 30849304
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of POLR1C-dependent Type 3 Treacher Collins Syndrome revealed by a zebrafish model.
Lau MC; Kwong EM; Lai KP; Li JW; Ho JC; Chan TF; Wong CK; Jiang YJ; Tse WK
Biochim Biophys Acta; 2016 Jun; 1862(6):1147-58. PubMed ID: 26972049
[TBL] [Abstract][Full Text] [Related]
4. The transcription of the main gene associated with Treacher-Collins syndrome (TCOF1) is regulated by G-quadruplexes and cellular nucleic acid binding protein (CNBP).
Gil Rosas M; Centola C; Torres M; Mouguelar VS; David AP; Piga EJ; Gomez D; Calcaterra NB; Armas P; Coux G
Sci Rep; 2024 Mar; 14(1):7472. PubMed ID: 38553547
[TBL] [Abstract][Full Text] [Related]
5. Fishing the molecular bases of Treacher Collins syndrome.
Weiner AM; Scampoli NL; Calcaterra NB
PLoS One; 2012; 7(1):e29574. PubMed ID: 22295061
[TBL] [Abstract][Full Text] [Related]
6. POLR1B and neural crest cell anomalies in Treacher Collins syndrome type 4.
Sanchez E; Laplace-Builhé B; Mau-Them FT; Richard E; Goldenberg A; Toler TL; Guignard T; Gatinois V; Vincent M; Blanchet C; Boland A; Bihoreau MT; Deleuze JF; Olaso R; Nephi W; Lüdecke HJ; Verheij JBGM; Moreau-Lenoir F; Denoyelle F; Rivière JB; Laplanche JL; Willing M; Captier G; Apparailly F; Wieczorek D; Collet C; Djouad F; Geneviève D
Genet Med; 2020 Mar; 22(3):547-556. PubMed ID: 31649276
[TBL] [Abstract][Full Text] [Related]
7. The Roles of RNA Polymerase I and III Subunits Polr1c and Polr1d in Craniofacial Development and in Zebrafish Models of Treacher Collins Syndrome.
Noack Watt KE; Achilleos A; Neben CL; Merrill AE; Trainor PA
PLoS Genet; 2016 Jul; 12(7):e1006187. PubMed ID: 27448281
[TBL] [Abstract][Full Text] [Related]
8. p53 inhibitor or antioxidants reduce the severity of ethmoid plate deformities in zebrafish Type 3 Treacher Collins syndrome model.
Ulhaq ZS; You MS; Jiang YJ; Tse WKF
Int J Biol Macromol; 2024 May; 266(Pt 2):131216. PubMed ID: 38556235
[TBL] [Abstract][Full Text] [Related]
9. Treacher Collins syndrome: unmasking the role of Tcof1/treacle.
Sakai D; Trainor PA
Int J Biochem Cell Biol; 2009 Jun; 41(6):1229-32. PubMed ID: 19027870
[TBL] [Abstract][Full Text] [Related]
10. Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.
Dixon J; Jones NC; Sandell LL; Jayasinghe SM; Crane J; Rey JP; Dixon MJ; Trainor PA
Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13403-8. PubMed ID: 16938878
[TBL] [Abstract][Full Text] [Related]
11. Tissue specific roles for the ribosome biogenesis factor Wdr43 in zebrafish development.
Zhao C; Andreeva V; Gibert Y; LaBonty M; Lattanzi V; Prabhudesai S; Zhou Y; Zon L; McCann KL; Baserga S; Yelick PC
PLoS Genet; 2014 Jan; 10(1):e1004074. PubMed ID: 24497835
[TBL] [Abstract][Full Text] [Related]
12. The Treacher Collins syndrome (TCOF1) gene product is involved in pre-rRNA methylation.
Gonzales B; Henning D; So RB; Dixon J; Dixon MJ; Valdez BC
Hum Mol Genet; 2005 Jul; 14(14):2035-43. PubMed ID: 15930015
[TBL] [Abstract][Full Text] [Related]
13. CNBP mediates neural crest cell expansion by controlling cell proliferation and cell survival during rostral head development.
Weiner AM; Allende ML; Becker TS; Calcaterra NB
J Cell Biochem; 2007 Dec; 102(6):1553-70. PubMed ID: 17471504
[TBL] [Abstract][Full Text] [Related]
14. Treacher Collins syndrome with a de Novo 5-bp deletion in the TCOF1 gene.
Su PH; Chen JY; Chen SJ; Yu JS
J Formos Med Assoc; 2006 Jun; 105(6):518-21. PubMed ID: 16801042
[TBL] [Abstract][Full Text] [Related]
15. Treacher Collins Syndrome: the genetics of a craniofacial disease.
Kadakia S; Helman SN; Badhey AK; Saman M; Ducic Y
Int J Pediatr Otorhinolaryngol; 2014 Jun; 78(6):893-8. PubMed ID: 24690222
[TBL] [Abstract][Full Text] [Related]
16. Treacher Collins Syndrome: Genetics, Clinical Features and Management.
Marszałek-Kruk BA; Wójcicki P; Dowgierd K; Śmigiel R
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573374
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of apoptosis in the prefusion neural folds underlie the craniofacial disorder, Treacher Collins syndrome.
Dixon J; Brakebusch C; Fässler R; Dixon MJ
Hum Mol Genet; 2000 Jun; 9(10):1473-80. PubMed ID: 10888597
[TBL] [Abstract][Full Text] [Related]
18. Face off against ROS: Tcof1/Treacle safeguards neuroepithelial cells and progenitor neural crest cells from oxidative stress during craniofacial development.
Sakai D; Trainor PA
Dev Growth Differ; 2016 Sep; 58(7):577-85. PubMed ID: 27481486
[TBL] [Abstract][Full Text] [Related]
19. tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
Watt KEN; Neben CL; Hall S; Merrill AE; Trainor PA
Hum Mol Genet; 2018 Aug; 27(15):2628-2643. PubMed ID: 29750247
[TBL] [Abstract][Full Text] [Related]
20. Novel mutations of TCOF1 gene in European patients with Treacher Collins syndrome.
Conte C; D'Apice MR; Rinaldi F; Gambardella S; Sangiuolo F; Novelli G
BMC Med Genet; 2011 Sep; 12():125. PubMed ID: 21951868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
